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Abstract
Background: In Australia, 40% of people diagnosed with cancer will be of working age (25–64 years). A cancer
diagnosis may lead to temporary or permanent changes in a person’s labour force participation, which has an
economic impact on both the individual and the economy. However, little is known about this economic impact of
cancer due to lost productivity in Australia. This paper aims to determine the labour force participation
characteristics of people with cancer, to estimate the indirect cost due to lost productivity, and to identify any
inequality in the distribution of labour force absence in Australia.
Methods: This study used national cross-sectional data from the 2015 Survey of Disability, Ageing and Carers,
conducted by the Australian Bureau of Statistics (ABS). The ABS weighted each component of the survey to
ensure the sample represented the population distribution of Australia. The analysis was limited to people aged
25–64 years. Participants were assigned to one of three health condition groups: ‘no health condition’, ‘cancer’, and
‘any other long-term health condition’. A series of logistic regression models were constructed to determine the
association between health condition and labour force participation.
Results: A total of 34,393 participants surveyed were aged 25–64 years, representing approximately 12,387,800
Australians. Almost half (46%) of people with cancer were not in the labour force, resulting in a reduction of $1.7
billion to the Australian gross domestic product (GDP). Amongst those in the labour force, people with no health
condition were 3.00 times more likely to be employed full-time compared to people with cancer (95% CI 1.96–4.57)
, after adjusting for age, sex, educational attainment and rurality. Amongst those with cancer, people without a
tertiary qualification were 3.73 times more likely to be out of the labour force (95% CI 1.97–7.07).
Conclusions: This paper is the first in Australia to estimate the national labour force participation rates of people
with cancer. People with cancer were less likely to be in the labour force, resulting in a reduction in Australia’s GDP.
Cancer survivors, especially those without a tertiary qualification may benefit from support to return to work after a
diagnosis.
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Background
Cancer is the leading burden of disease in Australia [1]
and internationally [2]. In 2017, an estimated 134,174
Australians will be diagnosed with cancer, of which 40%
will be of working age (25–64 years) [3]. Using the 2003
Survey of Disability, Ageing and Carers, Schofield et
al. [4] found that half (49%) of older Australians (aged
45–64 years) with cancer were not in the labour force.
In a more recent Australian study of 255 cancer patients,
67% reported changes to their employment [5]. A system-
atic literature review of employment and work-related is-
sues in cancer survivors included 64 international studies
and found that over a six-year period after a cancer diag-
nosis, 26–53% of cancer survivors were out of work (lost
their job or quit) [6]. Similarly, a recent meta-analysis of
international studies found that compared to healthy con-
trol participants, cancer survivors were 1.4 times more
likely to be unemployed [7]. These studies focus on the
individual perspective, and highlight the important finan-
cial distress faced by individual cancer patients and their
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families due to being out of the labour force [5, 8–12].
However, to date there has been minimal focus on the
societal perspective in Australia, and the consideration of
the aggregate costs of these changes in workforce partici-
pation; nor has there been consideration of the distribu-
tion of the costs of labour force absence, looking at the
population groups most likely to be affected. Such infor-
mation could be more useful to policy makers, concerned
with maximising welfare to the whole of society.
Health economic evaluations routinely evaluate the dir-
ect cost of illness; however, the indirect cost of lost prod-
uctivity due to morbidity and premature mortality may
exceed the direct costs of cancer [13–17]. In Europe, the
estimated cost of lost productivity from cancer in 2009 was
42%, a further 18% was attributed to the cost of informal
care, and only 41% of costs were attributed to direct health
care [18]. The National Institute of Health estimated that
in 2010, the cost of lost productivity in the United States
accounted for 61% of the total cost of cancer, compared to
39% for the direct costs [15]. In Korea, the estimated mor-
bidity and premature mortality costs accounted for 55% of
the total cost of cancer, compared to 28% for medical care
in 2009 [17]. In New South Wales, Australia in 2005, lost
productivity accounted for 54% of the total lifetime cost of
cancer, compared to the direct costs which accounted for
29% of the total lifetime costs [13]. However, this report
was from a single state in Australia. Carter, Schofield and
Shrestha [19] recently estimated that approximately 88,000
working years were lost, due to premature deaths from
cancer in 2003 in Australia, which cost $4.2 billion in
present value of lifetime income. Lung and colorectal
cancers accounted for 30% of the total loss of income. This
study provides a national perspective of the cost of cancer
due to premature mortality; however, there is currently
limited work on the productivity cost for people with can-
cer who are out of the labour force.
This paper will contribute to the growing body of re-
search on the indirect costs of cancer. The aims of this
research conducted within an Australian context are to:
1) determine whether people with cancer have different
labour force participation characteristics to people with
no health conditions, or any other long term health
conditions, 2) estimate the cost of cancer due to lost
productivity (limited to the context of paid work) and 3)
identify any inequality in the distribution of labour force
absence amongst those with cancer.
Methods
Data
The primary data source accessed for this data was the
2015 Survey of Disability, Ageing and Carers (SDAC).
This is a national survey conducted every 3 years by the
Australian Bureau of Statistics (ABS). The SDAC sam-
ple was a randomly selected sample of the Australian
population, regardless of health condition or disability
status and included participants from both household and
cared-accommodation, but excluded those residing in
prisons/correctional institutes, religious and/or educational
institutes; very remote areas, and discrete Indigenous com-
munities. The sample frame comprised approximately
25,500 private dwellings, 250 self-care retirement, and a
further 1000 cared-accommodation facilities. To adjust for
any potential bias in survey participants, the ABS weight
the survey data against known population benchmarks.
Briefly, the weight value indicates how many of the popula-
tion unit each sample unit represents. The two compo-
nents were weighted separately, the household component
was benchmarked to the estimated resident population in
each jurisdiction, and the cared accommodation compo-
nent was benchmarked to the census population counts of
this component as described in detail by the ABS [20].
Weighting allows an inference of results to the general
Australian population.
The survey included questions on demographics (such
as age, sex, highest level of education achievement, and
geographical remoteness), labour force participation, and
long-term health conditions (LTHC). LTHC’s were
defined by the SDAC as a condition lasting, or was likely
to last 6 months or more, or symptoms in the previous
12 months for an episodic condition (ie asthma or epi-
lepsy) and coded by the ABS based upon the ICD-10
[20]. Although the original survey included answers for
specific medical conditions, the ABS regrouped some
conditions for data release. For example, the types of can-
cer were grouped by the ABS: skin cancer (ICD C43–44),
breast cancer (ICD C50), prostate cancer (C61), bowel/
colorectal cancers (C18–21) and any other neoplasm
(including benign tumours).
Statistical analysis
Analyses were limited to people aged 25–64 years. Ex-
cluding survey respondents under the age of 25 allowed
those most likely to be participating in higher education
to be excluded; and those over the age of 65 were ex-
cluded, as the traditional retirement in Australia in 2015
was 65 years. Participants were categorised into one of
three health condition groups: ‘no LTHC’ included those
who did not report any LTHC, ‘cancer’ included those
who reported having cancer (skin, breast, prostate,
bowel/colorectal or any other neoplasm) as a LTHC, and
‘any other LTHC’ included those who reported any other
LTHC. Labour force participation (LFP) was recorded as
employed full-time (FT), employed part-time (PT),
unemployed but looking for FT and/or PT work, and
not in the labour force (NILF).1 Educational attainment
was recoded into a dichotomous variable (tertiary vs
non-tertiary education); as was rurality (major cities and
other), and age (25–44 years and 45–64 years).
Bates et al. BMC Public Health  (2018) 18:375 Page 2 of 7
Aim 1: Labour force participation of people with cancer
A series of logistic regression models were constructed to
determine the association between cancer and LFP.
Initially, the analysis was limited to include those in the
labour force only. A logistic regression model was con-
structed to estimate the odds of being employed full-time
for people with cancer, LTHC, and no health condition
(respectively), after adjusting for age, sex, educational
attainment and rurality. A second logistic regression
model was constructed to estimate the odds of being out
of the labour force for people with cancer, LTHC, and no
health condition (respectively), after adjusting for age, sex,
educational attainment and rurality.
Aim 2: Cost of labour force absence associated with
cancer
Using the same approach as other Australian studies
[21–25], the financial impact to Australia’s gross domes-
tic product (GDP) due to people with cancer being out
of the labour force was estimated using the Australian
Treasury’s formula [26]:
GDP ¼ GDP=Hð Þ x H=EMPð Þ x EMP=LFð Þ
x LF=Pop15þð Þ x Pop15þ
where GDP = gross domestic product; H = total hours
worked; EMP = total number of persons employed; LF =
total labour force; and Pop15+ = population aged 15 years
and over [26].
This method has been previously used in other studies
[21–25], and differs from the friction cost method,
which argues that people who leave the labour force due
will be replaced by other workers (including those who
were previously unemployed) thus limiting the cost of
workers leaving the labour force [27]. Australia has a
very low unemployment rate (6.3% in July 2015) [28]
and significant labour shortages in some industries
[29], furthermore, the Australian Treasury’s aim to
make Australia’s financial position more sustainable by
promoting productivity, population growth and labour
force participation [30], recognising the signficiant
cost labour force exit has on the Australian economy.
Aim 3: Inequality in the distribution of labour force
absence amongst those with cancer
A concentration index was initially used to determine
whether there was any inequality in the distribution of
labour force absence amongst people with cancer. The
concentration index is normally used as a measure of
health inequality, and assesses the distribution of health
outcomes across socioeconomic groups in a population.
The concentration index reflects the cumulative propor-
tion of health held by the cumulative proportion of the
population, ranked by a measure of socioeconomic
status. The measure of socioeconomic status used was
the highest level of education attainment achieved, as
reported in the survey (7 ordinal categories: Year 8 or
below, Year 10, Year11/12, Certificate, Diploma, Bach-
elor, Post-graduate). The concentration index ranges
from − 1 to 1, with a value of 0 denoting perfect equality
in the distribution of labour force absence, a negative
value denoting a distribution skewed towards people of
lower socioeconomic status, and a positive value denot-
ing a distribution skewed towards people of higher so-
cioeconomic status. The concentration index (CI), and






¼ αþ βRi þ εi
Where σ2R is the variance of Ri (the individual’s rank),
yi is the labour force status of each individual (i = 1, 2,
3….N), α is the intercept, εi is the error terms, and β is
the CI 1. Finally, among only people with cancer, a
multivariate logistic regression model was constructed to
estimate the odds of being not in the labour force, after
accounting for age, sex, educational attainment, and
rurality.
All analyses were undertaken using SAS V9.4 (SAS
Institute Inc., Cary, NC, USA). Weighted estimates are
presented, unless stated otherwise. GDP figures are pre-
sented in 2015 Australian dollars.
Results
Within the 2015 SDAC, a total of 34,393 participants were
of working age (25–64 years), which represented approxi-
mately 12,387,800 people when weighted. Of the partici-
pants in this age group, there were 7,287,100 with no
health conditions, 108,900 people with a type of cancer,
and 4,991,800 with some other LTHC. Table 1 shows the
demographic characteristics for each of the health condi-
tion categories (no LTHC, cancer, and any other LTHC).
Aim 1: Labour force participation of people with cancer
Table 2 shows the employment status for people with no
health condition, people with cancer, and people with
any other LTHC. Almost half (46%) of people with can-
cer were not in the labour force, compared to approxi-
mately a quarter (27%) of people with any other LTHC,
and only 12% of people with no health condition.
Firstly, the analyses were limited to people who were
in the labour force. Of those with cancer who were
employed, 47% were employed full time, compared with
68% of those with any other LTHC, and 74% of those
with no health condition. Amongst those in the labour
force, after adjusting for age, sex, educational attainment
and rurality, those with no health condition had 3.00
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times the odds of being employed full-time than people
with cancer (95% CI 1.96–4.57; p < 0.0001). Similarly,
those with any other LTHC had 2.15 times the odds of
being employed full-time (95% CI 1.41–3.28; p = 0.0004)
than those with cancer.
Secondly, the odds of being out of the labour force
were calculated. Table 3 shows that after adjusting for
age, sex, educational attainment and rurality, those with
no health condition, and those with any other long-term
health condition had lower odds of being out of the
labour force compared to adults with cancer.
Aim 2: Cost of labour force absence associated with
cancer
An estimated 50,100 Australian adults of working age
(25–64 years) with cancer were not in the labour force
in 2015, thereby reducing Australia’s GDP by approxi-
mately $1.7 billion (Table 4).
Table 1 SDAC sample demographic characteristics of Australian
adults of working age, 25–64 years (using weighted totals,
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LTHC long-term health condition



































LTHC long-term health condition, FT full-time, PT part-time, NILF not in the
labour force, have not looked for work in the last 4 weeks, and do not intend
to work or look for work in the future
aThe number and percentage of people who were ‘unemployed’ were not
presented due to low unemployment rate in Australia, and hence the low
sample number of unemployed people
Table 3 Logistic regression model of being not in the labour force
Parameter Estimate Standard Error P-Value
Intercept −2.49 0.16 < 0.001
Male 0.97 0.35 < 0.001
Aged 25–44 0.35 0.03 < 0.001
Tertiary education attainment 0.70 0.04 < 0.001
Lives in major city 0.04 0.04 0.2255
No LTHC −1.68 0.14 < 0.001
Any other LTHC −0.81 0.14 < 0.001
Odds of being out of the labour force
Odds Ratioa 95% CI P-value
Cancer Reference
No LTHC 0.19 0.14–0.25 < 0.001
Any other LTHC 0.45 0.34–0.58 < 0.001
LTHC long-term health condition
aadjusted OR = adjusted for age, sex, educational attainment, and rurality
Table 4 The proportion of people out of the labour force, and














50,100 108,900 46% $1738 million
Sex
Male 19900a 46,600 43% $690 million
Female 30300a 62,300 49% $1051 million
Age
25–44 years 6900 18,500 37% $239 million
45–64 years 43,200 90,400 48% $1499 million
Educational attainment
Non-tertiary 42,100 75,500 56% $1460 million
Tertiary 7500 30,100 25% $260 million
Rurality
Major cities 32,100 74,500 43% $1114 million
Other areas 18,000 34,400 52% $624 million
arounded up
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Aim 3: Inequality in the distribution of labour force
absence amongst those with cancer
The concentration index showing level of inequality in
the distribution of labour force absence amongst people
with cancer was calculated to be − 0.20 (95% CI -0.26 to
− 0.13), which indicates that having cancer and being
not in the labour force is unequally skewed towards
those with a low educational attainment.
Amongst people with cancer, those without a tertiary
qualification were 3.73 times more likely to be out of the
labour force (95% CI 1.97–7.07; p < 0.0001), than people
with tertiary education. Sex, age, and rurality were not
associated with being out of the labour force (p = 0.0818,
p = 0.3723, p = 0.1869 respectively).
Discussion
The results of this paper have shown that in 2015, al-
most half (46%) of adults of working age (25 to 64 years)
with cancer were not in the labour force. Of those in the
labour force, adults with no health conditions had 3
times the odds of being employed full-time than adults
with cancer. Other studies have supported our findings
that following a cancer diagnosis, many patients report a
temporary or permanent change to their labour force
participation, including a reduction in work hours and
stopping work [5, 6, 8, 9, 11, 31–34].
Amongst people with cancer, a greater proportion of
older people (45–64 years) were not in the labour force,
however, this appears to be explained by other demo-
graphic factors. Amongst people with cancer, those with-
out a tertiary qualification had nearly four times the odds
of being out of the labour force; age, sex, and rurality were
not associated with a greater risk. Higher education attain-
ment has been identified as a positive factor in returning
to work [6, 35], which also supports our findings that
labour force absence amongst those with cancer is un-
equally skewed towards those with lower levels of educa-
tion attainment. Other factors which may affect returning
to work include jobs that require manual labour, and those
with less flexible working arrangements [6, 8, 10, 32, 33].
The type of cancer and treatment factors may also nega-
tively impact returning to work [6, 7, 10, 35]. For example,
Clarke et al. [35] found that colorectal and lung cancer
survivors had greater difficulties performing daily activ-
ities, and colorectal, lung, and bladder cancer survivors
were more likely to have functional limitations, which
may impact work ability.
This paper looked at distribution of people being out
of the labour force for any reason, with some people
potentially being out of the labour force directly as a
result of cancer, while others may have chosen early
retirement [11] due to a reassessment of their priorities
following a health shock. In Australia, employees (excluding
casual employees) are entitled to paid sick leave (10 days
each year for full-time employees), and unpaid leave for up
to 3 months [36]. While the Australian retirement age in
2015 was 65 years, at which time individuals may be eligible
to access a government ‘age pension’, individuals may have
access to their superannuation from age 55. However, pre-
vious work has found that despite these sources of financial
support, early retirement due to LTHC has a significant
negative impact on an individual’s income and wealth
[22, 25]. As such cancer survivors may benefit from
additional support by the Government, employers and
medical professionals to facilitate returning to work if
they choose to. Previous studies have shown that many
cancer survivors will return to work after treatment,
from 40% at six-months to 89% at 24-months following
a cancer diagnosis [6].
A key strength of this paper is that it used the 2015
SDAC, which is a national survey weighted to the Austra-
lian population. Participants who identified as having
cancer as a long-term health condition represented 0.9%
of the weighted population. It was estimated that around
1.5% of the Australian population had cancer in 2011–12
[37]. However, we limited our analyses to people of work-
ing age only (25–64 years), which excluded people over
75 years, who had the highest rate of developing cancers
(11.1% for men and 4.4% for women) [37]. Therefore, this
study was representative of the Australian population of
working age.
However, the use of the SDAC also has several limita-
tions. This survey did not include information about the
time since diagnosis, which may be a factor in labour
force participation [8, 9, 12]. Secondly, although the
main types of cancer in Australia (skin, breast, prostate,
and colorectal cancer) are identified in the SDAC, the
number of participants in each type was small, and
therefore, disaggregated analysis by type of cancer was
not possible. Finally, it is possible that some types of
cancers, which may have minimal impacts on returning
to work, may have been over-estimated, particularly if
someone recently had the lesion removed. For example,
non-melanoma skin cancers are the most common type
of cancer in Australia, and in some cases, the cancer is
completely removed with a biopsy, or removed by surgi-
cal excision [38, 39]. We only included LTHC in our
analyses, which was defined in the survey as conditions
lasting or expected to last 6-months [20], which should
exclude cases in which the only treatment received was
complete removal of the lesion.
This paper provides an insight into the economic
burden of cancer due to labour force participation, and
builds upon the growing body of literature. However, we
acknowledge that this is only a small part of the larger
burden of cancer, and are currently conducting a larger
study on the cost of cancer to the healthcare system and
the individual [40]. Future research also should look at
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the distribution of labour force participation rates across
the different types of cancer to ensure equitable access
and allocation of resources.
Conclusion
A large proportion of Australians diagnosed with cancer
are of working age, and in general cancer survival rates
are improving [3]. Furthermore, in light of the increase
of the Australian retirement age, from the current 65 to
67 years by 2023 (increasing by 6 months every 2 years
commencing July 2017 [41]), it is reasonable to expect
that the cost of lost productivity may increase in the
coming years. There is a call for support systems to
facilitate return to work for cancer survivors who want
to work [42]. For some survivors, returning to work after
a cancer diagnosis is an important milestone, both finan-
cially and emotionally [33, 43]. Cancer survivors without a
tertiary qualification may benefit from additional support.
This paper is the first in Australia to estimate the national
labour force participation rates of adults of working age
with cancer, and the indirect cost of cancer due to lost
productivity. This information is valuable when consider-
ing how cancer affects patients and society.
Endnote
1Not in the Labour Force defined as not in the labour
force, and have not looked for work in the last 4 weeks,
and do not intend on working or looking for work in the
future.
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